7 alpha-hydroxy-4-cholesten-3-one and Cholangiitis, Sclerosing

7 alpha-hydroxy-4-cholesten-3-one has been researched along with Cholangiitis, Sclerosing in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beuers, U; Chazouillères, O; DePaoli, AM; Drenth, JP; Harrison, SA; Hirschfield, GM; Jaros, MJ; Karsdal, MA; Kim, KH; Landis, CS; Leeming, DJ; Ling, L; Mayo, MJ; Muir, AJ; Rossi, SJ; Somaratne, RM; Thorburn, D; Trotter, JF	1
Abdelghany, O; Assis, DN; Boyer, JL; Cai, SY; Ciarleglio, M; Deng, Y; Eaton, JE; Gossard, AA; Keach, JC; Lindor, KD; Setchell, KD	1
Beuers, U; de Vries, EM; de Waart, DR; Groen, AK; Jansen, PL; Koelfat, KV; Lenicek, M; Olde Damink, SW; Ponsioen, C; Schaap, FG; Tolenaars, D; Zweers, SJ	1
Berr, F; Beuers, U; Fischer, S; Paumgartner, G; Sauter, G	1

Trials

2 trial(s) available for 7 alpha-hydroxy-4-cholesten-3-one and Cholangiitis, Sclerosing

Article	Year
Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial. Journal of hepatology, 2019, Volume: 70, Issue:3 Topics: Alkaline Phosphatase; Bile Acids and Salts; Biomarkers; Biopsy; Cholangiography; Cholangitis, Sclerosing; Cholestenones; Cholesterol 7-alpha-Hydroxylase; Double-Blind Method; Drug Monitoring; Fibroblast Growth Factors; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Treatment Outcome	2019
Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot Study. Journal of clinical gastroenterology, 2017, Volume: 51, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Alkaline Phosphatase; Bile Acids and Salts; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestenones; Drug Therapy, Combination; Female; Humans; Liver; Liver Function Tests; Male; Middle Aged; Pilot Projects; Treatment Outcome; Tretinoin; Ursodeoxycholic Acid; Young Adult	2017

Article

Year

Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial.

Journal of hepatology, 2019, Volume: 70, Issue:3

Topics: Alkaline Phosphatase; Bile Acids and Salts; Biomarkers; Biopsy; Cholangiography; Cholangitis, Sclerosing; Cholestenones; Cholesterol 7-alpha-Hydroxylase; Double-Blind Method; Drug Monitoring; Fibroblast Growth Factors; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Treatment Outcome

2019

Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot Study.

Journal of clinical gastroenterology, 2017, Volume: 51, Issue:2

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Alkaline Phosphatase; Bile Acids and Salts; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestenones; Drug Therapy, Combination; Female; Humans; Liver; Liver Function Tests; Male; Middle Aged; Pilot Projects; Treatment Outcome; Tretinoin; Ursodeoxycholic Acid; Young Adult

2017

Other Studies

2 other study(ies) available for 7 alpha-hydroxy-4-cholesten-3-one and Cholangiitis, Sclerosing

Article	Year
Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge. Hepatology international, 2017, Volume: 11, Issue:1 Topics: Administration, Oral; Adult; Aged; Case-Control Studies; Cathartics; Chenodeoxycholic Acid; Cholangitis, Sclerosing; Cholestenones; Clinical Protocols; Female; Fibroblast Growth Factors; Humans; Intestinal Mucosa; Liver; Male; Middle Aged	2017
Serum concentrations of 7alpha-hydroxy-4-cholesten-3-one reflect bile acid synthesis in humans. Hepatology (Baltimore, Md.), 1996, Volume: 24, Issue:1 Topics: Adult; Bile Acids and Salts; Bilirubin; Biomarkers; Body Mass Index; Body Weight; Carbon Isotopes; Cholangitis, Sclerosing; Cholelithiasis; Cholestasis; Cholestenones; Deuterium; Female; Gas Chromatography-Mass Spectrometry; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Radioisotope Dilution Technique	1996

Article

Year

Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge.

Hepatology international, 2017, Volume: 11, Issue:1

Topics: Administration, Oral; Adult; Aged; Case-Control Studies; Cathartics; Chenodeoxycholic Acid; Cholangitis, Sclerosing; Cholestenones; Clinical Protocols; Female; Fibroblast Growth Factors; Humans; Intestinal Mucosa; Liver; Male; Middle Aged

2017

Serum concentrations of 7alpha-hydroxy-4-cholesten-3-one reflect bile acid synthesis in humans.

Hepatology (Baltimore, Md.), 1996, Volume: 24, Issue:1

Topics: Adult; Bile Acids and Salts; Bilirubin; Biomarkers; Body Mass Index; Body Weight; Carbon Isotopes; Cholangitis, Sclerosing; Cholelithiasis; Cholestasis; Cholestenones; Deuterium; Female; Gas Chromatography-Mass Spectrometry; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Radioisotope Dilution Technique

1996